Evaluation of Online Training on Provider Use of the Maryland PDMP
-
2019/07/01
Details
-
Corporate Authors:
-
Description:Conclusions and Recommendations: At baseline, most participants agreed with the value of the PDMP in a variety of clinical situations. However, their reported behavior did not correspond with the value they placed on the PDMP. This project was not designed to exhaustively explore reasons prescribing providers do not routinely use the PDMP, but to try to determine whether this behavior can be influenced with training. It was difficult to recruit as many participants as we wanted. We believe this relates to lack of significant incentive and competing demands for time. Nonetheless, with 150 having completed the module, this produced a large amount of data. For future training projects, we recommend consideration of financial incentives to boost participation. This project demonstrated to the participants that there is value in the PDMP beyond the mandatory use before prescribing a controlled substance, by illustrating in fictional cases how data from the PDMP can significantly change the treatment plan. In each fictional case, the treatment plan changed for most respondents in response to the PDMP data provided. We had hoped to measure actual behavioral change following the training by comparing the pattern of accessing the PDMP before and after taking the module among participants and comparing this to the pattern of non-participants. Unfortunately, we were unable to obtain the requested data from CRISP. We recommend that MDH follow up with CRISP to obtain this information and make these comparisons, as this project offers a very rare opportunity to measure the actual impact of education. The follow-up survey offered some insight into changes post-training. Only 59 of 150 participants agreed to follow-up contact, and of these only 32 completed the follow-up survey, yielding a respectable 50% response rate. By self-report 20 of these 32 reported that they used the PDMP after the training as much as, or more than, they had planned to, and 12 reported using it less than they had planned to. Reasons included prescribing less opioids, practice factors and difficulties with the interface. This project yielded much more data that could be analyzed with the support of biostatisticians, and we recommend further such analysis with the plan to submit the findings for publication. We have engaged the services of the University of Maryland Baltimore Institute for Clinical Translational Research for such support and look forward to collaborating with you to prepare a manuscript sharing the findings of this project. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
Publisher:
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Pages in Document:1-28
-
NIOSHTIC Number:nn:20066309
-
Citation:Baltimore, MD: University of Maryland School of Medicine, 2019 Jul; :1-28
-
Federal Fiscal Year:2019
-
Performing Organization:Maryland State Department of Health, Baltimore
-
Peer Reviewed:False
-
Start Date:20160701
-
Source Full Name:Evaluation of online training on provider use of the Maryland PDMP
-
End Date:20260630
-
Collection(s):
-
Main Document Checksum:urn:sha-512:d35c5498406ba45f10b126c55bc8190050141fb3b6248ac7b3432450b2a6b2b573cc9ac844e9b05bbd6f9b933d38abba60fa818d7dd669f5582ba4dc3f4d6042
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like